Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Lilly Just Reported More Than Half of Patients on Its New Weight Loss Drug Lost 20% of Their Body Weight — and a Third Lost 25%. Here's How the News Could Shake Up the Obesity Drug Market.

Phase three trials on Eli Lilly's new weight loss drug, TRIUMPH-2, showed strong results.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at fool.com →

More in Finance & Markets

More from Wednesday 30 September →